Art

J-GLOBAL ID：202102215328425988   Reference number：21A0777996

JAK-STAT Signaling: A Double-Edged Sword of Immune Regulation and Cancer Progression

JAK-STATシグナリング:免疫調節と癌進行の両端剣【JST・京大機械翻訳】

Author (6)： Owen Katie L. (Cancer Immunology and Therapeutics Programs, Peter MacCallum Cancer Centre, VIC, Melbourne 3000, Australia) ,  Owen Katie L. (Sir Peter MacCallum Department of Oncology, University of Melbourne, VIC, Parkville 3052, Australia) ,  Brockwell Natasha K. (Cancer Immunology and Therapeutics Programs, Peter MacCallum Cancer Centre, VIC, Melbourne 3000, Australia) ,  Brockwell Natasha K. (Sir Peter MacCallum Department of Oncology, University of Melbourne, VIC, Parkville 3052, Australia) ,  Parker Belinda S. (Cancer Immunology and Therapeutics Programs, Peter MacCallum Cancer Centre, VIC, Melbourne 3000, Australia) ,  Parker Belinda S. (Sir Peter MacCallum Department of Oncology, University of Melbourne, VIC, Parkville 3052, Australia)
Material： Cancers (Web)
Volume： 11  Issue： 12  Page： 2002  Publication year： 2019 
JST Material Number： U7153A  ISSN： 2072-6694  Document type： Article
Article type： 文献レビュー  Country of issue： Switzerland (CHE)  Language： ENGLISH (EN)

Abstract/Point： Janus kinase-signal transducer...

Register(free) or Log In to access     To see more with JDream III (charged).   {{ this.onShowAbsJLink("http://jdream3.com/lp/jglobal/index.html?docNo=21A0777996&from=J-GLOBAL&jstjournalNo=U7153A") }}

Thesaurus term： interferon ,  inflammation ,  tumor ,  tumor cell ,  phenotype ,  immunosuppression ,  targeting ,  cellular signal transduction ,  tumor immunity ,  *STAT transcription factor
Semi thesaurus term： マイクロRNA ,  *腫瘍進行 ,  Janusキナーゼ ,  STAT3転写因子 ,  免疫回避 , 【Automatic Indexing@JST】

Author keywords (7)： JAK ,  STAT ,  signaling ,  interferons ,  immunosurveillance ,  inflammation ,  cancer

JST classification (1)： Cell physiology in general  (EF02010S)

Reference (235)：

• Thomas, S.J.; Snowden, J.A.; Zeidler, M.P.; Danson, S.J. The role of JAK/STAT signalling in the pathogenesis, prognosis and treatment of solid tumours. Br. J. Cancer 2015, 113, 365-371.
• Villarino, A.V.; Kanno, Y.; O’Shea, J.J. Mechanisms and consequences of Jak-STAT signaling in the immune system. Nat. Immunol. 2017, 18, 374-384.
• Groner, B.; von Manstein, V. Jak Stat signaling and cancer: Opportunities, benefits and side effects of targeted inhibition. Mol. Cell. Endocrinol. 2017, 451, 1-14.
• Jones, L.M.; Broz, M.L.; Ranger, J.J.; Ozcelik, J.; Ahn, R.; Zuo, D.; Ursini-Siegel, J.; Hallett, M.T.; Krummel, M.; Muller, W.J. STAT3 Establishes an Immunosuppressive Microenvironment during the Early Stages of Breast Carcinogenesis to Promote Tumor Growth and Metastasis. Cancer Res. 2016, 76, 1416-1428.
• Fuertes, M.B.; Kacha, A.K.; Kline, J.; Woo, S.-R.; Kranz, D.M.; Murphy, K.M.; Gajewski, T.F. Host type I IFN signals are required for antitumor CD8+ T cell responses through CD8α+ dendritic cells. J. Exp. Med. 2011, 208, 2005-2016.

Terms in the title (5)： JAK ,  Stat ,  シグナリング ,  免疫調節 ,  癌進行